Home Therapeutics Antibiotics

Antibiotics

    Random
    Antibiotics

    Cubist to Buy Calixa for $92.5M to Pad Anti-Infective Pipeline

    Antibiotics

    Durata Therapeutics Acquires Pfizer’s Subsidiary that Develops Antibiotics

    Antibiotics

    Optimer Reports Positive Phase III Data for Antibiotic against C. Difficile

    DTRA funding will evaluate and optimize compounds from marine natural product libraries. [© PinkShot - Fotolia.com]
    Antibiotics

    Trius Wins $29.5M Contract to Develop Antibiotics for Gram-Negative Pathogens

    Antibiotics

    Tetraphase Pockets $45M to Progress Next-Generation Tetracyclines

    Antibiotics

    DSM to Manufacture Novacta’s C. Difficile Compound for Preclinical and Phase...

    Antibiotics

    Aquapharm and AMRI Collaborate to Discover Marine-Derived Therapeutics

    Antibiotics

    Elusys Receives $40.6M under Government Contract for Anthrax Treatment

    Firm’s lead compound ACHN-490 will be evaluated against organism causing bubonic plague. [ggw/Fotolia.com]
    Antibiotics

    Achaogen Wins $64M BARDA Contract to Develop Antibiotic for Biothreats

    Antibiotics

    BD Diagnostics and Bruker Join Forces to Improve Antimicrobial Susceptibility Testing

    123...32Page 1 of 32
    Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.